Advertisement
Organisation › Details
TreeFrog Therapeutics SAS
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-StemTM technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 80 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M over the past 3 years to advance its pipeline of stem cell-based therapies in the field of neurodegeneration, cardio-metabolic disorders, and immuno-oncology. The company is currently opening technological hubs in Boston, USA, and Kobe, Japan, to drive the adoption of C-StemTM and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy. Since 2018, TreeFrog Therapeutics has been actively participating to the Japanese Society for Regenerative Medicine and the Link-J consortium, and is a Supporting Member of the CiRA Foundation. In 2020, TreeFrog Therapeutics launched a collaboration on iPSC quality with the Foundation for Biomedical Research and Innovation at Kobe (FBRI) and the Harvard Stem Cell Institute, which was awarded by the prestigious Prix Galien MedStartup Prize in New York. *
Start | 2018-12-07 established | |
Group | TreeFrog Therapeutics (Group) | |
Industry | C-Stem™ technology platform (based on 3D stem cell culture) | |
Industry 2 | stem cell therapy | |
Person | Desdouits, Frédéric (TreeFrog Therapeutics 202109– CEO before PCAS + Seqens + Pierre Fabre + Bionest Partners) | |
Person 2 | Alessandri, Kévin (TreeFrog Therapeutics 202201– Managing Director TreeFrog Tx Inc before CEO + CTO + Co-Founder) | |
Region | Bordeaux | |
Country | France | |
Street | 30 avenue Gustave Eiffel Bât A | |
City | 33600 Pessac (Bordeaux) | |
Tel | +33-7-6259-7498 | |
Address record changed: 2024-01-05 | ||
Basic data | Employees | B: 11 to 50 (2021-09-13) |
* Document for »About Section«: TreeFrog Therapeutics SAS. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe. | ||
Record changed: 2024-03-30 |
Advertisement
More documents for TreeFrog Therapeutics (Group)
- [1] TreeFrog Therapeutics SAS. (6/10/22). "Press Release: Umoja Biopharma and TreeFrog Therapeutics Announce Collaboration to Address Current Challenges Facing ex vivo Allogeneic Therapies in Immuno-oncology". Seattle, WA & Pessac....
- [2] TreeFrog Therapeutics SAS. (4/14/22). "Press Release: TreeFrog Therapeutics Expands Board with New Independent Members from the Cell Therapy Industry". Bordeaux....
- [3] TreeFrog Therapeutics SAS. (4/8/22). "Press Release: TreeFrog Therapeutics Opens Technological Hub in Kobe, Japan, to Drive Partnerships Opportunities in the Field of iPSC-derived Cell Therapies". Kobe....
- [4] TreeFrog Therapeutics SAS. (9/13/21). "Press Release: TreeFrog Therapeutics Secures $75M in Series B Financing to Advance a Pipeline of Stem Cell-derived Cell therapies and Deploy Proprietary C-Stem Technology in the USA & Japan". Bordeaux....
- [5] TreeFrog Therapeutics SAS. (4/12/21). "Press Release: World first – TreeFrog Therapeutics Announces the Production of a Single Batch of 15 Billion iPS cells in a 10L Bioreactor with Exponential Amplification of 276-fold per Week". Bordeaux....
- [6] TreeFrog Therapeutics SAS. (6/9/20). "Press Release: TreeFrog Therapeutics Opens Its First Facility Dedicated to iPS Cell Therapy Scale-up in Bordeaux, France". Bordeaux....
- [7] TreeFrog Therapeutics SAS. (2/5/20). "Press Release: TreeFrog Therapeutics Brings in Senior Profiles to Drive the Advent of High-quality and Affordable Allogenic Cell Therapies". Bordeaux....
- [8] TreeFrog Therapeutics SAS. (9/5/19). "Press Release: TreeFrog Therapeutics Receives Additional €3m Non-dilutive Funding". Bordeaux....
- [9] TreeFrog Therapeutics SAS. (5/13/19). "Press Release: TreeFrog Therapeutics Raises over €7M ($7.8M) in Series A Financing Round 6 Months after Incorporation". Bordeaux....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top